India’s diabetes care devices market eyes 4% CAGR growth until 2033

Thanks to increasing awareness, technological adoption, and improved information access.

India’s diabetes care devices market is projected to rise at a compound annual growth rate of approximately 4% through 2033, said GlobalData.

The sector’s expansion is attributed to increasing awareness, technological adoption, and improved access to information.

Moreover, the country accounted for around 20% of the Asia-Pacific market in 2024. Increased diagnosis, higher disposable incomes, and tech advancements have contributed to this growth.

Meanwhile, artificial intelligence (AI)-driven solutions are expected to play a key role in diabetes management.

Ongoing research in AI focuses on predictive glucose models, automated insulin delivery systems, and risk assessment tools, said Shreya Jain, Medical Devices Analyst at GlobalData.

“The field still faces key challenges related to lack of transparency, personalisation, and integration with existing systems that require innovative approaches to enhance prediction accuracy and ensure effective implementation,” Jain added.